# Signadori Bio

**Source:** https://www.startuphub.ai/startups/signadori-bio
**Profile type:** Startup

> Developing a next-generation, off-the-shelf, in vivo engineered monocyte immunotherapy platform for solid tumors.

## About

Signadori Bio SAS is a preclinical-stage biopharmaceutical company focused on developing an innovative immunotherapy platform. Their approach utilizes in vivo engineered monocytes, designed to be an off-the-shelf solution for treating solid tumors. The company aims to advance novel therapeutic strategies in oncology.

## Key facts

- **Slug:** signadori-bio
- **Website:** https://www.signadoribio.com/
- **Location:** Paris, France
- **Founded:** 2025-01-01
- **Operating status:** Inactive
- **Total funding:** $12M
- **Sectors / tags:** Biotechnology, Pharmaceuticals, Oncology, Immunotherapy, Biopharmaceuticals, Drug Discovery, Cell Therapy, Solid Tumors, Innate Immunity, Monocytes, Cancer Treatment

## Frequently asked

### What does Signadori Bio do?

Signadori Bio SAS is a preclinical-stage biopharmaceutical company focused on developing an innovative immunotherapy platform. Their approach utilizes in vivo engineered monocytes, designed to be an off-the-shelf solution for treating solid tumors. The company aims to advance novel therapeutic strategies in oncology.

### What is Signadori Bio's revenue?

StartupHub estimates Signadori Bio's annual revenue at $974K (range $285K to $3.9M, 34% confidence), based on comparable companies in the sector.

### What is Signadori Bio's valuation?

StartupHub estimates Signadori Bio's effective valuation at $47.6M (range $30.5M to $73.2M, 23% confidence), based on comparable companies in the sector.

### How much funding has Signadori Bio raised?

Signadori Bio has raised a total of $12M in funding. The most recent round on record is Seed Extension.

### Where is Signadori Bio headquartered?

Signadori Bio is headquartered in Paris, France.

### When was Signadori Bio founded?

Signadori Bio was founded in 2025.

### What industry does Signadori Bio operate in?

Signadori Bio operates in Biotechnology, Pharmaceuticals, Oncology, Immunotherapy, Biopharmaceuticals, Drug Discovery.

### What is Signadori Bio's current status?

Signadori Bio's current operating status is: Inactive.

## JSON-LD

Structured data aligned with this page's `<script type="application/ld+json">` (included when the profile is server-rendered).

```json
{
  "@context": "https://schema.org",
  "@graph": [
    {
      "@type": "BreadcrumbList",
      "itemListElement": [
        {
          "@type": "ListItem",
          "position": 1,
          "name": "Home",
          "item": "https://www.startuphub.ai"
        },
        {
          "@type": "ListItem",
          "position": 2,
          "name": "Startups",
          "item": "https://www.startuphub.ai/startups"
        },
        {
          "@type": "ListItem",
          "position": 3,
          "name": "Signadori Bio",
          "item": "https://www.startuphub.ai/startups/signadori-bio"
        }
      ]
    },
    {
      "@type": "ProfilePage",
      "@id": "https://www.startuphub.ai/startups/signadori-bio#webpage",
      "url": "https://www.startuphub.ai/startups/signadori-bio",
      "name": "Signadori Bio - AI Startup Profile | StartupHub.ai",
      "description": "This is the official profile of Signadori Bio. Signadori Bio is a startup founded in 2025, operating in Biotechnology and Pharmaceuticals. Developing a next-generation, off-the-shelf, in vivo engineered monocyte immunotherapy platform for solid tumors. Headquartered in Paris, France.",
      "dateModified": "2026-05-10T06:00:35.423+00:00",
      "mainEntity": {
        "@id": "https://www.startuphub.ai/startups/signadori-bio#organization"
      }
    },
    {
      "@type": "Organization",
      "@id": "https://www.startuphub.ai/startups/signadori-bio#organization",
      "name": "Signadori Bio",
      "url": "https://www.signadoribio.com/",
      "logo": "https://cdn.startuphub.ai/storage/v1/object/public/entity-images/logos/bcf8ab45-5c4d-4d3b-938d-1d16b9999965-square.webp",
      "image": "https://cdn.startuphub.ai/storage/v1/object/public/entity-images/logos/bcf8ab45-5c4d-4d3b-938d-1d16b9999965-square.webp",
      "description": "This is the official profile of Signadori Bio. Signadori Bio is a startup founded in 2025, operating in Biotechnology and Pharmaceuticals. Developing a next-generation, off-the-shelf, in vivo engineered monocyte immunotherapy platform for solid tumors. Headquartered in Paris, France.",
      "sameAs": [
        "https://www.startuphub.ai/startups/signadori-bio"
      ],
      "foundingDate": "2025-01-01",
      "address": {
        "@type": "PostalAddress",
        "addressLocality": "Paris",
        "addressCountry": "France"
      },
      "knowsAbout": [
        "Biotechnology",
        "Pharmaceuticals",
        "Oncology",
        "Immunotherapy",
        "Biopharmaceuticals",
        "Drug Discovery",
        "Cell Therapy",
        "Solid Tumors",
        "Innate Immunity",
        "Monocytes",
        "Cancer Treatment"
      ]
    }
  ]
}
```